ANJANA BHRANY: Open Payments
NPI 1891741443 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 84 payments from 13 companies in 2025. Trend: 2023 $2,255 · 2024 $1,471 · 2025 $1,364
Food & beverage: $1,364
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $222 |
| Janssen Pharmaceuticals, Inc | 6 | $187 |
| Neurocrine BioSciences, Inc. | 11 | $163 |
| E.R. Squibb & Sons, L.L.C. | 13 | $153 |
| Alkermes, Inc. | 7 | $144 |
| Teva Pharmaceuticals USA, Inc. | 8 | $136 |
| ABBVIE INC. | 17 | $136 |
| Vanda Pharmaceuticals Inc. | 4 | $78 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $43 |
| Lundbeck LLC | 2 | $40 |
Products named: INVEGA SUSTENNA, INGREZZA, COBENFY, ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI.
Industry payments across MI — which companies pay providers there.
